Ionis Pharmaceuticals, Inc. (IONS) Discusses FDA Approval of TRYNGOLZA for Severe Hypertriglyceridemia and Acute Pancreatitis Risk Reduction Transcript
Emerging markets equities have been overshadowed for years now by the raw performance of U.S. stocks. That doesn't mean investors should ignore the opportunities therein.
The semiconductor market has seen immense growth over the past year, and that momentum continues with Micron Technology (MU) blowing analyst expectations out of the water. Expect ETFs offering pure play exposure to the memory semiconductor industry to benefit in at least the near-term future.
The muni bond landscape picked up significant interest to end 2025, with investors clamoring for the yields available therein. American Century Investments Vice President and Senior Portfolio Manager Joe Gotelli recently sat down with VettaFi to talk about the muni bonds outlook.
Ionis wins FDA approval to expand Tryngolza to severe hypertriglyceridemia, opening a broader market as the first approved treatment for the condition.
Warren Buffett buys businesses that compound dividends rather than businesses that pay the biggest dividend they can squeeze out today.
Stellar's milestone highlights its growing role in bridging traditional finance with blockchain, potentially reshaping institutional asset settlement. Stellar network's real-world assets market cap surpasses $3B.
Tesla (NASDAQ:TSLA | TSLA Price Prediction) has been one of 2026's most-debated stocks, swinging between
BXP signs a long-term 320,000-square-foot lease with Boston Dynamics at Reservoir Place. This represents one of Greater Boston's largest innovation office deals this year.
Strategy's debt buyback over Bitcoin acquisition signals a shift in priorities, raising concerns about sustainability and market confidence. Strategy bonds trade below par as Saylor faces pressure over massive BTC holdings.
Few stocks have fallen as far, as fast, as Figma (NYSE:FIG).
Shares of FuelCell Energy (NASDAQ:FCEL) are down 10% in Thursday afternoon trading, leading a profit-taking reversal across some fuel cell names.
Salesforce (NYSE:CRM | CRM Price Prediction) and Palantir (NASDAQ:PLTR) both delivered blowout quarters this spring, yet the market punished each stock.
Abbott Laboratories (NYSE:ABT | ABT Price Prediction) at $90.53 is a Buy.
Fundstrat Granny Shots US Large Cap ETF earns a reiterated "Buy" rating, outperforming the S&P 500 by 2.5 percentage points since July 2025. GRNY's portfolio is now more balanced, reducing tech exposure below 30% and increasing cyclicals, positioning for a market rally broadening. The ETF's weighted-average long-term EPS growth rate is nearly 14%, with a mid-20s P/E multiple, reflecting a premium to the S&P 500.
NVIDIA (NASDAQ:NVDA | NVDA Price Prediction) and Advanced Micro Devices (NASDAQ:AMD) both posted earnings confirming AI infrastructure dominates semis.
SpaceX (NASDAQ:SPCX) is the only ticker financial media wants to discuss this week after its blockbuster public debut at an implied trillion-dollar valuation.
Eastman Chemical (NYSE: EMN | EMN Price Prediction) is a Kingsport, Tennessee specialty materials company whose molecular recycling (methanolysis) facility is reshaping its cash flow profile.
The Layer 2 network Starknet announced the integration of advanced privacy features for the USDC stablecoin through its new native framework STRK20.
NZD/USD Price Forecast: RSI flashes oversold as the pair hovers near seven-month lows
Gold price rebounds as US Dollar's rally stalls despite high Core PCE
Babylon announced a partnership with Aegis to develop a fixed-rate credit product backed by native Bitcoin, with no need to wrap assets, perform bridges to other networks or surrender custody. The solution will combine Babylon Trustless Bitcoin Vaults, Aave v4 and Aegis's fixed-rate lending infrastructure, and is expected to be available in Q4 2026, subject to development and testing.
It defies what most in the music biz have believed until now: Spotify pays itself more than what it pays to the record labels, according to a streaming royalty calculator launched by leading law firm Manatt Phelps & Phillips.
Shares of Palantir Technologies extended their recent slide on Thursday, falling for a seventh consecutive trading session and putting the stock on track for its lowest close in more than a year. Palantir shares dropped 5.8% to $106.88 during trading.
Baillie Gifford's reported tokenized bond fund plans add another traditional asset manager to the race to bring regulated funds onto public blockchain rail
Volatility is strongly returning to cryptocurrencies as a wave of selling hits digital assets. In this tense context, the official Dogecoin account chose humor to comment on the situation.
Apple could be starting to feel the squeeze from rising memory costs.
I have a $386.80 intrinsic value for Salesforce. With the current price of $150.12, this represents a 158% upside. I believe CRM is getting thrown out with the proverbial bathwater due to the fear that AI capabilities are making legacy software business models obsolete (SaaSpocalypse). CRM has over 20 years of formulating customer relationships AND gaining their trust in collecting their data, analyzing/utilizing it, and designing custom enterprise/vertical workflows. That is not something that can be.
Kraken's investment in Aave signals a strategic shift towards DeFi, potentially reshaping financial markets by bridging digital and traditional assets. Kraken eyes Aave stake at $385 million valuation: Report.
AFRM's latest merchant win with Backcountry expands its BNPL reach and could help drive higher spending on outdoor gear.